Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study

Data on asthma treatment outcomes in Africa are limited. 449 patients with asthma (age 5–93 years) in Uganda were followed up for 2 years to determine rates of exacerbations and mortality and associated factors. During follow-up the median number of exacerbations per patient was 1 (IQR 0–5) and 17 p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2018-10, Vol.73 (10), p.983-985
Hauptverfasser: Kirenga, Bruce J, de Jong, Corina, Mugenyi, Levicatus, Katagira, Winceslaus, Muhofa, Abdallah, Kamya, Moses R, Boezen, H Marike, van der Molen, Thys
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 985
container_issue 10
container_start_page 983
container_title Thorax
container_volume 73
creator Kirenga, Bruce J
de Jong, Corina
Mugenyi, Levicatus
Katagira, Winceslaus
Muhofa, Abdallah
Kamya, Moses R
Boezen, H Marike
van der Molen, Thys
description Data on asthma treatment outcomes in Africa are limited. 449 patients with asthma (age 5–93 years) in Uganda were followed up for 2 years to determine rates of exacerbations and mortality and associated factors. During follow-up the median number of exacerbations per patient was 1 (IQR 0–5) and 17 patients died (3.7%, 27.3 deaths per 1000 person years). Considering only the first year of follow-up, 59.6% of the patients experienced at least one exacerbation, 32.4% experienced three or more exacerbations. A multivariable model showed that the likelihood of experiencing at least one exacerbation in the first year of follow-up was lower with better baseline asthma control (higher asthma control test (ACT) score), with OR 0.87 (95% CI: 0.82 to 0.93, P=0.000), and was higher with more exacerbations in the year prior to enrolment (OR for log number of exacerbations 1.28, 95% CI: 1.04 to 1.57, P=0.018). Better asthma control (OR 0.93, 95% CI: 0.88 to 0.99, P=0.021) and number of baseline exacerbations (OR 1.35,95% CI: 1.11 to 1.66, P=0.005) were also the only factors that were independently associated with experiencing three or more exacerbations during the first year of follow-up. The only factor found to be associated with all-cause mortality was FEV1, with higher recent FEV1 associated with lower all-cause mortality (OR 0.30, 95% CI: 0.14 to 0.65; P=0.002). Rates of asthma exacerbations and mortality are high in Uganda and are associated with poor asthma control. Health systems should be strengthened to care for asthma patients.
doi_str_mv 10.1136/thoraxjnl-2017-211157
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2038271160</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2038271160</sourcerecordid><originalsourceid>FETCH-LOGICAL-b491t-33e6b44fc60a1d281a6cacfb8563e497f895eee34d796958e11f3c76d3a0ef6d3</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxS0EokvhI4Ascekl4LETO-mtWpU_UiUkRM_WxBnTrJJ4aztV99vjsqWHnjiNRvN7T89-jL0H8QlA6c_5JkS83y1TJQWYSgJAY16wDdS6rZTs9Eu2EaIWlVZGn7A3Ke2EEC2Aec1OZGcaqWq9YeEnZko8eI4p38zI6R4dxR7zGJbEcRn4HGLGacyHvxumFNxYRAP36HKIiY8Lv_5dbnjOkcvqQBj5Poa0J5fHO-IulKyZp7wOh7fslccp0bvHecquv1z-2n6rrn58_b69uKr6uoNcKUW6r2vvtEAYZAuoHTrft41WVHfGt11DRKoeTKe7piUAr5zRg0JBvoxTdnb0LUFuV0rZzmNyNE24UFiTlUK10gBoUdCPz9BdWONS0tnyqw1IbURXqOZIufKyFMnbfRxnjAcLwj40Yp8asQ-N2GMjRffh0X3tZxqeVP8qKIA4Av28-0_PP0z6mkc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2115126709</pqid></control><display><type>article</type><title>Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kirenga, Bruce J ; de Jong, Corina ; Mugenyi, Levicatus ; Katagira, Winceslaus ; Muhofa, Abdallah ; Kamya, Moses R ; Boezen, H Marike ; van der Molen, Thys</creator><creatorcontrib>Kirenga, Bruce J ; de Jong, Corina ; Mugenyi, Levicatus ; Katagira, Winceslaus ; Muhofa, Abdallah ; Kamya, Moses R ; Boezen, H Marike ; van der Molen, Thys</creatorcontrib><description>Data on asthma treatment outcomes in Africa are limited. 449 patients with asthma (age 5–93 years) in Uganda were followed up for 2 years to determine rates of exacerbations and mortality and associated factors. During follow-up the median number of exacerbations per patient was 1 (IQR 0–5) and 17 patients died (3.7%, 27.3 deaths per 1000 person years). Considering only the first year of follow-up, 59.6% of the patients experienced at least one exacerbation, 32.4% experienced three or more exacerbations. A multivariable model showed that the likelihood of experiencing at least one exacerbation in the first year of follow-up was lower with better baseline asthma control (higher asthma control test (ACT) score), with OR 0.87 (95% CI: 0.82 to 0.93, P=0.000), and was higher with more exacerbations in the year prior to enrolment (OR for log number of exacerbations 1.28, 95% CI: 1.04 to 1.57, P=0.018). Better asthma control (OR 0.93, 95% CI: 0.88 to 0.99, P=0.021) and number of baseline exacerbations (OR 1.35,95% CI: 1.11 to 1.66, P=0.005) were also the only factors that were independently associated with experiencing three or more exacerbations during the first year of follow-up. The only factor found to be associated with all-cause mortality was FEV1, with higher recent FEV1 associated with lower all-cause mortality (OR 0.30, 95% CI: 0.14 to 0.65; P=0.002). Rates of asthma exacerbations and mortality are high in Uganda and are associated with poor asthma control. Health systems should be strengthened to care for asthma patients.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thoraxjnl-2017-211157</identifier><identifier>PMID: 29752346</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Airway management ; Asthma ; Asthma - complications ; Asthma - epidemiology ; Asthma - mortality ; Child ; Child, Preschool ; Chronic obstructive pulmonary disease ; Clinical outcomes ; Cohort analysis ; Cohort Studies ; Demographics ; Disease Progression ; Ethics ; Female ; Follow-Up Studies ; Funding ; Humans ; Male ; Middle Aged ; Mortality ; Patients ; Prospective Studies ; Registries ; Risk Factors ; Smoking ; Tuberculosis ; Uganda - epidemiology ; Young Adult</subject><ispartof>Thorax, 2018-10, Vol.73 (10), p.983-985</ispartof><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b491t-33e6b44fc60a1d281a6cacfb8563e497f895eee34d796958e11f3c76d3a0ef6d3</citedby><cites>FETCH-LOGICAL-b491t-33e6b44fc60a1d281a6cacfb8563e497f895eee34d796958e11f3c76d3a0ef6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29752346$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirenga, Bruce J</creatorcontrib><creatorcontrib>de Jong, Corina</creatorcontrib><creatorcontrib>Mugenyi, Levicatus</creatorcontrib><creatorcontrib>Katagira, Winceslaus</creatorcontrib><creatorcontrib>Muhofa, Abdallah</creatorcontrib><creatorcontrib>Kamya, Moses R</creatorcontrib><creatorcontrib>Boezen, H Marike</creatorcontrib><creatorcontrib>van der Molen, Thys</creatorcontrib><title>Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study</title><title>Thorax</title><addtitle>Thorax</addtitle><description>Data on asthma treatment outcomes in Africa are limited. 449 patients with asthma (age 5–93 years) in Uganda were followed up for 2 years to determine rates of exacerbations and mortality and associated factors. During follow-up the median number of exacerbations per patient was 1 (IQR 0–5) and 17 patients died (3.7%, 27.3 deaths per 1000 person years). Considering only the first year of follow-up, 59.6% of the patients experienced at least one exacerbation, 32.4% experienced three or more exacerbations. A multivariable model showed that the likelihood of experiencing at least one exacerbation in the first year of follow-up was lower with better baseline asthma control (higher asthma control test (ACT) score), with OR 0.87 (95% CI: 0.82 to 0.93, P=0.000), and was higher with more exacerbations in the year prior to enrolment (OR for log number of exacerbations 1.28, 95% CI: 1.04 to 1.57, P=0.018). Better asthma control (OR 0.93, 95% CI: 0.88 to 0.99, P=0.021) and number of baseline exacerbations (OR 1.35,95% CI: 1.11 to 1.66, P=0.005) were also the only factors that were independently associated with experiencing three or more exacerbations during the first year of follow-up. The only factor found to be associated with all-cause mortality was FEV1, with higher recent FEV1 associated with lower all-cause mortality (OR 0.30, 95% CI: 0.14 to 0.65; P=0.002). Rates of asthma exacerbations and mortality are high in Uganda and are associated with poor asthma control. Health systems should be strengthened to care for asthma patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Airway management</subject><subject>Asthma</subject><subject>Asthma - complications</subject><subject>Asthma - epidemiology</subject><subject>Asthma - mortality</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Clinical outcomes</subject><subject>Cohort analysis</subject><subject>Cohort Studies</subject><subject>Demographics</subject><subject>Disease Progression</subject><subject>Ethics</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Funding</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Smoking</subject><subject>Tuberculosis</subject><subject>Uganda - epidemiology</subject><subject>Young Adult</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkU9v1DAQxS0EokvhI4Ascekl4LETO-mtWpU_UiUkRM_WxBnTrJJ4aztV99vjsqWHnjiNRvN7T89-jL0H8QlA6c_5JkS83y1TJQWYSgJAY16wDdS6rZTs9Eu2EaIWlVZGn7A3Ke2EEC2Aec1OZGcaqWq9YeEnZko8eI4p38zI6R4dxR7zGJbEcRn4HGLGacyHvxumFNxYRAP36HKIiY8Lv_5dbnjOkcvqQBj5Poa0J5fHO-IulKyZp7wOh7fslccp0bvHecquv1z-2n6rrn58_b69uKr6uoNcKUW6r2vvtEAYZAuoHTrft41WVHfGt11DRKoeTKe7piUAr5zRg0JBvoxTdnb0LUFuV0rZzmNyNE24UFiTlUK10gBoUdCPz9BdWONS0tnyqw1IbURXqOZIufKyFMnbfRxnjAcLwj40Yp8asQ-N2GMjRffh0X3tZxqeVP8qKIA4Av28-0_PP0z6mkc</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Kirenga, Bruce J</creator><creator>de Jong, Corina</creator><creator>Mugenyi, Levicatus</creator><creator>Katagira, Winceslaus</creator><creator>Muhofa, Abdallah</creator><creator>Kamya, Moses R</creator><creator>Boezen, H Marike</creator><creator>van der Molen, Thys</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20181001</creationdate><title>Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study</title><author>Kirenga, Bruce J ; de Jong, Corina ; Mugenyi, Levicatus ; Katagira, Winceslaus ; Muhofa, Abdallah ; Kamya, Moses R ; Boezen, H Marike ; van der Molen, Thys</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b491t-33e6b44fc60a1d281a6cacfb8563e497f895eee34d796958e11f3c76d3a0ef6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Airway management</topic><topic>Asthma</topic><topic>Asthma - complications</topic><topic>Asthma - epidemiology</topic><topic>Asthma - mortality</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Clinical outcomes</topic><topic>Cohort analysis</topic><topic>Cohort Studies</topic><topic>Demographics</topic><topic>Disease Progression</topic><topic>Ethics</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Funding</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Smoking</topic><topic>Tuberculosis</topic><topic>Uganda - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirenga, Bruce J</creatorcontrib><creatorcontrib>de Jong, Corina</creatorcontrib><creatorcontrib>Mugenyi, Levicatus</creatorcontrib><creatorcontrib>Katagira, Winceslaus</creatorcontrib><creatorcontrib>Muhofa, Abdallah</creatorcontrib><creatorcontrib>Kamya, Moses R</creatorcontrib><creatorcontrib>Boezen, H Marike</creatorcontrib><creatorcontrib>van der Molen, Thys</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirenga, Bruce J</au><au>de Jong, Corina</au><au>Mugenyi, Levicatus</au><au>Katagira, Winceslaus</au><au>Muhofa, Abdallah</au><au>Kamya, Moses R</au><au>Boezen, H Marike</au><au>van der Molen, Thys</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>73</volume><issue>10</issue><spage>983</spage><epage>985</epage><pages>983-985</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>Data on asthma treatment outcomes in Africa are limited. 449 patients with asthma (age 5–93 years) in Uganda were followed up for 2 years to determine rates of exacerbations and mortality and associated factors. During follow-up the median number of exacerbations per patient was 1 (IQR 0–5) and 17 patients died (3.7%, 27.3 deaths per 1000 person years). Considering only the first year of follow-up, 59.6% of the patients experienced at least one exacerbation, 32.4% experienced three or more exacerbations. A multivariable model showed that the likelihood of experiencing at least one exacerbation in the first year of follow-up was lower with better baseline asthma control (higher asthma control test (ACT) score), with OR 0.87 (95% CI: 0.82 to 0.93, P=0.000), and was higher with more exacerbations in the year prior to enrolment (OR for log number of exacerbations 1.28, 95% CI: 1.04 to 1.57, P=0.018). Better asthma control (OR 0.93, 95% CI: 0.88 to 0.99, P=0.021) and number of baseline exacerbations (OR 1.35,95% CI: 1.11 to 1.66, P=0.005) were also the only factors that were independently associated with experiencing three or more exacerbations during the first year of follow-up. The only factor found to be associated with all-cause mortality was FEV1, with higher recent FEV1 associated with lower all-cause mortality (OR 0.30, 95% CI: 0.14 to 0.65; P=0.002). Rates of asthma exacerbations and mortality are high in Uganda and are associated with poor asthma control. Health systems should be strengthened to care for asthma patients.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29752346</pmid><doi>10.1136/thoraxjnl-2017-211157</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2018-10, Vol.73 (10), p.983-985
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_miscellaneous_2038271160
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Airway management
Asthma
Asthma - complications
Asthma - epidemiology
Asthma - mortality
Child
Child, Preschool
Chronic obstructive pulmonary disease
Clinical outcomes
Cohort analysis
Cohort Studies
Demographics
Disease Progression
Ethics
Female
Follow-Up Studies
Funding
Humans
Male
Middle Aged
Mortality
Patients
Prospective Studies
Registries
Risk Factors
Smoking
Tuberculosis
Uganda - epidemiology
Young Adult
title Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A32%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rates%20of%20asthma%20exacerbations%20and%20mortality%20and%20associated%20factors%20in%20Uganda:%20a%202-year%20prospective%20cohort%20study&rft.jtitle=Thorax&rft.au=Kirenga,%20Bruce%20J&rft.date=2018-10-01&rft.volume=73&rft.issue=10&rft.spage=983&rft.epage=985&rft.pages=983-985&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thoraxjnl-2017-211157&rft_dat=%3Cproquest_cross%3E2038271160%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2115126709&rft_id=info:pmid/29752346&rfr_iscdi=true